Victor V. Moroz

Victor V. Moroz

Auto-generated profile, based on publicly available information

Victor V. Moroz

Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2025 in General Reanimatology
Verified
Journal Article
Open access
PDF file
AKArtem Kuzovlev
Artem Kuzovlev
VBV. A. Boboshko
V. A. Boboshko
EBEkaterina Boeva
Ekaterina Boeva
EGEvgeny Grigoryev
Evgeny Grigoryev
PDP. A. Davydov
P. A. Davydov
STS. V. Tsarenko
S. V. Tsarenko
These guidelines were developed by a team of leading experts and representatives of the Federation of Anesthesiologists and Reanimatologists, the Russian Society of Emergency Medicine, the National Resuscitation Council and the Russian Society of First Aid.The guidelines provide a comprehensive framework for resuscitating adult patients with circulatory arrest. They cover: standardized terminology related to cardiac arrest; etiology and pathogenesis of cardiac arrest; epidemiology of both out-of-hospital and in-hospital cardiac arrest; diagnostic principles; algorithms for basic life support, including the use of automated external defibrillators; advanced cardiac life support protocols; special considerations for extracorporeal life support (ECLS); resuscitation procedures in catheterization laboratories, for cardiac surgery patients, and during labor; legal aspects of justified withdrawal (termination) from resuscitation efforts; quality indicators in emergency care.The guidelines also feature illustrated step-by-step algorithms for resuscitation procedures. The document includes 14 appendices and 232 references.

24 April 2024 in General Reanimatology
Verified
Journal Article
Open access
PDF file
DFD. L. Fetlam
D. L. Fetlam
ACA. G. Chumachenko
A. G. Chumachenko
MVM. D. Vyazmina
M. D. Vyazmina
VMV. V. Moroz
V. V. Moroz
AKArtem Kuzovlev
Artem Kuzovlev
VPVladimir Pisarev
Vladimir Pisarev
The mortality rate among patients with acute suppurative lung diseases (ASLD) in the ICU reaches 30%. Early, pathogenetically relevant biomarkers are needed to ensure personification and better efficacy of ASLD treatment. Numeric variations in the counts of immune system cells in patient’s blood can be viewed as such candidate biomarkers.The aim of the study. Identification of potential markers predicting ASLD outcome after community-acquired pneumonia and COVID-19.Materials and methods. The study included 216 in-hospital patients aged 18-87 with ASLD after community-acquired pneumonia with (N=81) and without (N=135) COVID-19 history.Results. Patients survival after COVID-19 was linked to lymphocyte count on Day 1 of hospital stay (hazard ratio, HR=5.9 95%CI 0.9–37.4; P=0.0188, log-rank test). In patients who had not have COVID-19, a difference in survival was associated with lymphocyte (HR=2.9 95%CI 1.0–8.4; P=0.0184, log-rank test; N=135), and monocyte counts (HR=2.7 95% CI 0.8–9.5; P=0.0196, log-rank test) on Day 1 of hospital stay. Patients’ survival after COVID-19 infection depended on SII (systemic immune-inflammation index. HR=9.3 95%CI 1.7–49.8; P=0.0124, log-rank test; N=81, SIRI (systemic inflammatory response index, HR=7.2 95%CI 1.4–36.6; P=0.0339, log-rank test; N=81) and NLR (neutrophil-to-lymphocyte ratio, HR=9.6 95%CI 1.8–52.0; P=0.0108; log-rank test; N=81) values on Day 1 of hospital stay. In patients who did not have COVID-19 SII values had no influence on survival.Conclusion. The lymphocyte count makes it possible to predict outcomes of pleural empyema, regardless of patient’s history of COVID-19, i. e. a decrease in the lymphocyte count below 1.2×10⁹ in 1 L is associated with fatal outcome. Monocyte count carries prognostic information for cases of pleural empyema without previous COVID-19 infection. As for the relative indicators, SIRI, SII and NLR values measured on Day 1 in the hospital were predictors of ASLD outcome only in patients after COVID-19 infection, i. e., higher values were associated with increased risk of death, with NLR index being the most informative. Overall severity of illness above 10 scores by CIRS was associated with an unfavorable ASLD outcome, regardless of patient’s history of COVID-19.

26 March 2019 in Annals of Critical Care
Verified
Journal Article
Open access
AKArtem Kuzovlev
Artem Kuzovlev
VMV. V. Moroz
V. V. Moroz
Nosocomial pneumonia and nosocomial tracheobronchitis present an urgent problem of anesthesiology and critical care medicine. This review presents the results of our own research on the informativity of new molecular biomarkers in the early diagnosis of nosocomial pneumonia, as well as modern principles for the prevention of nosocomial pneumonia. A promising direction for the early diagnosis of nosocomial pneumonia and its complications is the study of new molecular biomarkers, in particular, Clara cell protein and surfactant proteins. Effective prevention of nosocomial pneumonia should be based on a complex of modern evidence-based methods.

1 January 2016 in General Reanimatology
Verified
Journal Article
Open access
PDF file
AMA. E. Myazin
A. E. Myazin
ACA. G. Chumachenko
A. G. Chumachenko
AKArtem Kuzovlev
Artem Kuzovlev
AGA. M. Golubev
A. M. Golubev
VMV. V. Moroz
V. V. Moroz
VPVladimir Pisarev
Vladimir Pisarev
Цель исследования. Определить значение генетических вариантов сайта однонуклеотидного полиморфизма rs3736309 интрона 3 гена аквапорина5 (AQP5) в течении критических состояний у больных с документированной инфекцией легких. Материалы и методы. Обследована группа больных реанимационных отделений при развитии критических состояний (n=86, возраст — от 27 до 82 лет, средний возраст — 53,20±14,34 года). В выборке преобладали больные со злокачественными новообразованиями (15%), перитонитом (16%) и панкреонекрозом (37%). У 55% больных развилась нозокомиальная пневмония, острый респираторный дистресссиндром (ОРДС) — у 54% больных, септический шок — у 48% больных и у 33% ОРДС сочетался с септическим шоком. В лаважной жидкости всех больных были выявлены бактерии Pseudomonas aeruginosa, Klebsiella pneumoniae, Acinetobacter baumannii изолированно или в ассоциации, в т.ч. с Proteus mirabilis. Генотипирование ДНК проводили с использованием тетрапраймерной полимеразной цепной реакции. Статистическую обработку осуществляли при помощи программы GraphPad InStat (GraphPad, USA). Результаты. Распределение частот генотипов AA, GA и GG AQP5 rs3736309) среди всей выборки подчинялось закону ХардиВайнберга (p=0,923) и соответствовало данным исследований условноздоровых индивидуумов в европеоидной популяции (p>0,05). Показано, что в подгруппе больных с септическим шоком генотипа AQP5 AA (rs3736309), начиная уже с 1го дня обследования, были выявлены более низкие значения ИВСВЛ по сравнению с больными генотипов GG и GA с септическим шоком, несмотря на одинаковые подходы к лечению критического состояния. Различия между генетически разными подгруппами больных с септическим шоком сохранялись на протяжении всего срока обследования (p<0,05, дни 1, 3, 5 и 7). Генетический вариант G+ AQP5 (rs3736309), таким образом, являлся неблагоприятным фактором, способствующим развитию отека легких, устойчивого к лечению (соотношение шансов, OR=6,75; p=0,032). Только в подгруппе больных с септическим шоком генотипа G+ (но не во всей группе больных или в подгруппе больных безсептического шока с тем же генотипом) было отмечен значительно более высокий уровень сурфактантного белка SPD в плазме по сравнению с больными генотипа AQP5 АА аналогичной подгруппы (p<0,05). Заключение. При септическом шоке наличие гомозиготного варианта аллеля А (АА) сайта полиморфизма гена AQP5 rs3736309 является благоприятным фактором при развитии отека легких. Наличие аллеля G AQP5 rs3736309 является фактором риска большей выраженности отека легких и его устойчивости к лечению.

19 January 2025 in Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care
Verified
Journal Article
Open access
PDF file
ASArtyom Yu. Smykov
Artyom Yu. Smykov
FSFedor G. Sharshov
Fedor G. Sharshov
IOIvan F. Ostreikov
Ivan F. Ostreikov
SKSergey E. Khoroshilov
Sergey E. Khoroshilov
VMVictor V. Moroz
Victor V. Moroz
ХЕХорошилов Сергей Е.
Хорошилов Сергей Е.
Multisystem inflammatory syndrome is an extremely severe form of coronavirus infection in children, which characterized by systemic hyperinflammation with multiple organ failure. In some cases, cardiovascular complications are reported, including myocardial dysfunction, myocardial ischemia, shock, arrhythmias, coronaritis and coronary artery aneurysms. Although the incidence of coronavirus infection has decreased, patient mortality from multisystem inflammatory syndrome remains high. A clinical case of COVID-associated multisystem inflammatory syndrome in an infant is presented. Since admission, the patient with a high titer of immunoglobulin G with SARS-CoV-2 showed signs of hyperinflammation with subsequent development of pericarditis and myocardial dysfunction associated with prolonged bilateral pneumonia. Coronaritis and aneurysm of the left coronary artery were diagnosed. The patient had a long history of reduced global contractile function and high levels of myocardial damage markers requiring prolonged inotropic support and use of cardiac glycosides. Later, paroxysmal tachycardia developed in addition to cardiovascular complications. Comprehensive management of the disease and early detection of complications resulted in a favorable outcome.

17 April 2024 in Messenger of ANESTHESIOLOGY AND RESUSCITATION
Verified
Journal Article
Open access
PDF file
NEN. V. Ermokhina
N. V. Ermokhina
AKArtem Kuzovlev
Artem Kuzovlev
DDD. V. Davydov
D. V. Davydov
AGAndrey Grechko
Andrey Grechko
PPPetr Polyakov
Petr Polyakov
VMV. V. Moroz
V. V. Moroz
The objective was to determine the prognostic value of predictors of early postoperative cognitive disorders in traumatological patients to assess the development of the main clinical outcomes (postoperative delirium and delayed neurocognitive recovery).Materials and methods. A two-center prospective cohort observational study of patients aged 45–74 years after planned traumatological operations (endoprosthetics of large joints of the lower extremities, spinal fusion surgery, transpedicular fixation of vertebrae) under general anesthesia with tracheal intubation was conducted in the period from March 2021 to June 2022. Before the operation, demographic indicators, concomitant diseases, background therapy, laboratory tests and testing (ASA, MoCA, AUDIT, CFS, HADS-A, RASS). At the end of the operation after extubation and in the postoperative period, patients were analyzed according to the scales RUS, CAM- ICU and CAM-ICU-7, NRS and BPS. Statistical analysis was carried out using the software SPSS Statistics 27.0.1.0.Results. The study included 200 patients. Early postoperative cognitive disorders (ePCD) (agitation and emergence delirium (ED)) 61 (30.5%) patients were diagnosed, 139 (69.5%) patients had adequate awakening in the operating room. Independent predictors of the development of ePCD were the age of patients (≥ 60), glucose level ≥ 5.6 and a high score on the Clinical Frailty Scale (≥ 4). The prevalence of postoperative delirium (POD) was 11% (22 patients). The independent risk factors for POD were the duration of hypotension and the presence of hyperactive ED. Delayed neurocognitive recovery after surgery and anesthesia was observed in 115 patients (57.8%). At the same time, a statistically significant predictor of this condition was the duration of hypotension for more than 15 minutes (sensitivity 59.18%, specificity 65.85%).Conclusion. When comparing the influence of the study group (patients with ePCD) with the control group, it was determined that ePCD is an independent risk factor for the development of POD (p < 0.001).